BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2300478
,
TGFB1
,
Fatty acid metabolic process
,
Influenza
,
Breast
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
neovascularization physiologic
Summary
General Info
Curated Studies
Most Correlated Studies
Endothelial progenitor cells treated with dihydrotestosterone (DHT)
Cross-talk between endometrial stromal cells and macrophages in culture
Lung microvascular endothelial cells exposed to ionizing radiation
Effect of Actin cytoskeleton abnormalities due to DSTN deficiency on cornea
Explore Curated Studies Results
Literature
Most Relevant Literature
Class 3 semaphorins and their receptors in physiological and pathological angiogenesis.
The vascular-disrupting agent combretastatin impairs splitting and sprouting forms of physiological …
Physiological angiogenesis is a graded, not threshold, response.
The role of wnt signaling in physiological and pathological angiogenesis.
The role of VEGF pathways in human physiologic and pathologic angiogenesis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Treatment of Corneal Neovascularization With Topical Pazopanib
Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related M…
12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)
Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular G…
Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patie…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ